Complement C4A and C4B gene copy number study in Alzheimer's disease patients

Michele Zorzetto, Francesca Datturi, Laura Divizia, Cristiana Pistono, Ilaria Campo, Annalisa De Silvestri, Mariaclara Cuccia, Giovanni Ricevuti

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background/Objectives: Increasing evidence suggests the importance of neuroinflammation in the pathogenesis of Alzheimer’s disease (AD), which is a complex neurodegenerative disorder. Complement activation occurs in the brain of patients with AD and seems to contribute to an important local inflammatory state. Increased expression of the fourth serum complement component 4 (C4) has been observed in AD patients in many studies. This protein has two isoforms, encoded by two genes: C4A and C4B localized to the HLA class III region. These genes exhibit copy number variations (CNVs) and this different gene copy number can influence C4 protein levels. We focalized our attention on these two genes, determining the distribution of CNVs in AD patients, compared with healthy controls, in order to analyse their possible involvement in AD pathogenesis. Methods: We investigated 191 AD patients and 300 healthy controls. The C4A and C4B copy numbers were assessed by quantitative PCR (qPCR). Results: The results obtained showed a statistically significant increase in the number of copies for both C4A and C4B in AD patients, compared with healthy controls (p<0,001). Conclusion: The presence of high C4A and C4B copy numbers in AD patients could explain the increased C4 protein expression observed in AD patients, thus highlighting a possible role for C4A and C4B CNVs in the risk of developing AD.

Original languageEnglish
Pages (from-to)303-308
Number of pages6
JournalCurrent Alzheimer Research
Volume14
Issue number3
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Gene Dosage
Alzheimer Disease
Complement C4
Proteins
Complement Activation
Neurodegenerative Diseases
Genes
Protein Isoforms
Polymerase Chain Reaction

Keywords

  • Alzheimer’s disease
  • C4A
  • C4B
  • Complement system
  • Inflammation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Complement C4A and C4B gene copy number study in Alzheimer's disease patients. / Zorzetto, Michele; Datturi, Francesca; Divizia, Laura; Pistono, Cristiana; Campo, Ilaria; De Silvestri, Annalisa; Cuccia, Mariaclara; Ricevuti, Giovanni.

In: Current Alzheimer Research, Vol. 14, No. 3, 01.03.2017, p. 303-308.

Research output: Contribution to journalArticle

Zorzetto, Michele ; Datturi, Francesca ; Divizia, Laura ; Pistono, Cristiana ; Campo, Ilaria ; De Silvestri, Annalisa ; Cuccia, Mariaclara ; Ricevuti, Giovanni. / Complement C4A and C4B gene copy number study in Alzheimer's disease patients. In: Current Alzheimer Research. 2017 ; Vol. 14, No. 3. pp. 303-308.
@article{5bc2e0c4086943f197a1f67126e09d18,
title = "Complement C4A and C4B gene copy number study in Alzheimer's disease patients",
abstract = "Background/Objectives: Increasing evidence suggests the importance of neuroinflammation in the pathogenesis of Alzheimer’s disease (AD), which is a complex neurodegenerative disorder. Complement activation occurs in the brain of patients with AD and seems to contribute to an important local inflammatory state. Increased expression of the fourth serum complement component 4 (C4) has been observed in AD patients in many studies. This protein has two isoforms, encoded by two genes: C4A and C4B localized to the HLA class III region. These genes exhibit copy number variations (CNVs) and this different gene copy number can influence C4 protein levels. We focalized our attention on these two genes, determining the distribution of CNVs in AD patients, compared with healthy controls, in order to analyse their possible involvement in AD pathogenesis. Methods: We investigated 191 AD patients and 300 healthy controls. The C4A and C4B copy numbers were assessed by quantitative PCR (qPCR). Results: The results obtained showed a statistically significant increase in the number of copies for both C4A and C4B in AD patients, compared with healthy controls (p<0,001). Conclusion: The presence of high C4A and C4B copy numbers in AD patients could explain the increased C4 protein expression observed in AD patients, thus highlighting a possible role for C4A and C4B CNVs in the risk of developing AD.",
keywords = "Alzheimer’s disease, C4A, C4B, Complement system, Inflammation",
author = "Michele Zorzetto and Francesca Datturi and Laura Divizia and Cristiana Pistono and Ilaria Campo and {De Silvestri}, Annalisa and Mariaclara Cuccia and Giovanni Ricevuti",
year = "2017",
month = "3",
day = "1",
doi = "10.2174/1567205013666161013091934",
language = "English",
volume = "14",
pages = "303--308",
journal = "Current Alzheimer Research",
issn = "1567-2050",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Complement C4A and C4B gene copy number study in Alzheimer's disease patients

AU - Zorzetto, Michele

AU - Datturi, Francesca

AU - Divizia, Laura

AU - Pistono, Cristiana

AU - Campo, Ilaria

AU - De Silvestri, Annalisa

AU - Cuccia, Mariaclara

AU - Ricevuti, Giovanni

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background/Objectives: Increasing evidence suggests the importance of neuroinflammation in the pathogenesis of Alzheimer’s disease (AD), which is a complex neurodegenerative disorder. Complement activation occurs in the brain of patients with AD and seems to contribute to an important local inflammatory state. Increased expression of the fourth serum complement component 4 (C4) has been observed in AD patients in many studies. This protein has two isoforms, encoded by two genes: C4A and C4B localized to the HLA class III region. These genes exhibit copy number variations (CNVs) and this different gene copy number can influence C4 protein levels. We focalized our attention on these two genes, determining the distribution of CNVs in AD patients, compared with healthy controls, in order to analyse their possible involvement in AD pathogenesis. Methods: We investigated 191 AD patients and 300 healthy controls. The C4A and C4B copy numbers were assessed by quantitative PCR (qPCR). Results: The results obtained showed a statistically significant increase in the number of copies for both C4A and C4B in AD patients, compared with healthy controls (p<0,001). Conclusion: The presence of high C4A and C4B copy numbers in AD patients could explain the increased C4 protein expression observed in AD patients, thus highlighting a possible role for C4A and C4B CNVs in the risk of developing AD.

AB - Background/Objectives: Increasing evidence suggests the importance of neuroinflammation in the pathogenesis of Alzheimer’s disease (AD), which is a complex neurodegenerative disorder. Complement activation occurs in the brain of patients with AD and seems to contribute to an important local inflammatory state. Increased expression of the fourth serum complement component 4 (C4) has been observed in AD patients in many studies. This protein has two isoforms, encoded by two genes: C4A and C4B localized to the HLA class III region. These genes exhibit copy number variations (CNVs) and this different gene copy number can influence C4 protein levels. We focalized our attention on these two genes, determining the distribution of CNVs in AD patients, compared with healthy controls, in order to analyse their possible involvement in AD pathogenesis. Methods: We investigated 191 AD patients and 300 healthy controls. The C4A and C4B copy numbers were assessed by quantitative PCR (qPCR). Results: The results obtained showed a statistically significant increase in the number of copies for both C4A and C4B in AD patients, compared with healthy controls (p<0,001). Conclusion: The presence of high C4A and C4B copy numbers in AD patients could explain the increased C4 protein expression observed in AD patients, thus highlighting a possible role for C4A and C4B CNVs in the risk of developing AD.

KW - Alzheimer’s disease

KW - C4A

KW - C4B

KW - Complement system

KW - Inflammation

UR - http://www.scopus.com/inward/record.url?scp=85013899272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013899272&partnerID=8YFLogxK

U2 - 10.2174/1567205013666161013091934

DO - 10.2174/1567205013666161013091934

M3 - Article

VL - 14

SP - 303

EP - 308

JO - Current Alzheimer Research

JF - Current Alzheimer Research

SN - 1567-2050

IS - 3

ER -